Introduction
============

In the USA, chronic obstructive pulmonary disease (COPD) affects 7% individuals in the age group of 25--75 years and is the 4th leading cause of mortality in North America and Europe ([@b1-etm-0-0-8026],[@b2-etm-0-0-8026]). This chronic progressive disease results in the gradual loss of lung function, eventually leading to hypoxemia and dyspnea, with patients complaining of chronic cough, sputum production and shortness of breath ([@b3-etm-0-0-8026]). Dyspnea from air-flow limitation usually restricts patients with COPD from performing strenuous physical activities with the resultant loss of strength and the endurance of skeletal muscles ([@b4-etm-0-0-8026]). Exercise intolerance is a characteristic of COPD and is observed in the early stages of the disease. The management of all patients with COPD, functionally disabled by breathlessness, includes pulmonary rehabilitation (PR) ([@b5-etm-0-0-8026],[@b6-etm-0-0-8026]). An integral component of PR is physical training, which can lead to significant improvements in exercise capacity, breathlessness, fatigue and health-related quality of life outcomes of patients with COPD ([@b7-etm-0-0-8026]). PR benefits individuals by decreasing minute ventilation for any given external work possibly by improving the metabolic capacity of skeletal muscles ([@b8-etm-0-0-8026]).

Oxygen supplementation has been an ergogenic aid for patients with COPD. Long-term oxygen therapy has been shown to be beneficial for patients with chronic resting hypoxemia ([@b9-etm-0-0-8026]). Ambulatory oxygen has also been used for the treatment of patients who experience hypoxemia during routine daily activities, but are normoxemic at rest ([@b10-etm-0-0-8026]). Several clinical trials have investigated the role of supplemental oxygen during exercise training in PR programs ([@b11-etm-0-0-8026]--[@b13-etm-0-0-8026]). Patients with exercise-induced desaturation may not tolerate high-intensity exercise and may require reduced intensity training during PR, thereby limiting its effectiveness ([@b5-etm-0-0-8026]). It is postulated that oxygen may enhance the exercise training of patients with COPD ([@b11-etm-0-0-8026]). The mechanism of supplemental oxygen in increasing exercise performance has been attributed to decreased ventilatory response, possibly due to a blunted carotid body drive or delayed lactic acidosis ([@b14-etm-0-0-8026]). The results of randomized controlled trials (RCTs) however, have been conflicting ([@b13-etm-0-0-8026],[@b15-etm-0-0-8026]). A Cochrane meta-analysis in 2007 reviewing 5 RCTs, reported limited evidence for oxygen supplementation during exercise training for individuals with COPD ([@b2-etm-0-0-8026]). There is thus a need for an updated systematic review and meta-analysis investigating the role of oxygen therapy during exercise training for patients with COPD.

Data and methods
================

### Selection criteria

The primary objective of this systematic review was to investigate the role of supplemental oxygen in improving outcomes following exercise training in patients with COPD. This study was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement ([@b16-etm-0-0-8026]) and guidelines of the Cochrane Handbook for Systematic Reviews of Intervention ([@b17-etm-0-0-8026]). Only RCTs evaluating the efficacy of supplementary oxygen therapy during the exercise training of patients with COPD were included. Abstracts, non-English language studies, uncontrolled studies and retrospective studies were excluded. The detailed inclusion and exclusion criteria applied for participants, interventions and outcomes are presented in [Table I](#tI-etm-0-0-8026){ref-type="table"}.

### Search strategy

PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL) and Google scholar databases (first 100 results) were electronically searched for articles published up to May, 2019. Key words used in various combinations were as follows: Oxygen therapy \[MeSH\], oxygen \[MeSH\], supplemental oxygen \[Free text\], chronic obstructive pulmonary disease \[MeSH\], chronic obstructive lung disease \[MeSH\], chronic obstructive airway disease \[MeSH\], pulmonary rehabilitation \[Free text\], exercise \[MeSH\], dyspnea \[MeSH\], quality of life \[MeSH\] and physical endurance \[MeSH\]. References of included studies and review articles were analyzed for the identification of any additional studies.

### Collection of data and analysis

Two independent reviewers examined potentially eligible studies for inclusion in the review. Following the removal of duplicates, studies were scrutinized by their title and abstracts. Full-texts of selected articles were then scanned for inclusion. Any difference in opinion was resolved by discussion. The following data from the included trials were extracted: Authors, publication year, study type, sample size, demographic data, interventions used, exercise protocol, outcomes assessed and study conclusions.

### Quality assessment

The Cochrane Collaboration risk assessment tool for RCTs was used for assessing the risk of bias ([@b18-etm-0-0-8026]). Seven criteria were evaluated for each study: Random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and other biases. The included studies were judged for each item and rated as 'high risk', 'low risk' or 'unclear risk'.

### Statistical analysis

Several variable exercise tests have been used for patients with COPD, such as maximal/incremental/progressive exercise tests, constant power/sub-maximal/endurance exercise tests, functional exercise tests and shuttle walk tests. Only results from the same exercise protocol were combined. Meta-analysis was conducted only if at least 3 studies reported data on the same scale. In studies where exercise outcomes were measured on oxygen and room air, only room air values were considered. Outcome data extracted were entered into Review Manager \[RevMan, version 5.3; Nordic Cochrane Centre (Cochrane Collaboration), Copenhagen, Denmark, 2014\] for quantitative analysis. Changes in outcome scores were used for the meta-analysis. In studies where change scores were missing, the following equation was used for calculating the change in mean and standard deviation (SD) scores: i) Mean (change) = mean (after)-mean (before); ii) SD (change) = square root {\[SD^2^ (after)-SD^2^ (before)\]/2}.

Considering the heterogeneity amongst studies, a random-effects model was used to calculate the pooled effect size. The mean difference (SMD) with 95% confidence interval (CI) was used for combining the data. Heterogeneity was calculated using the I^2^ statistic. I^2^ values of 25--50% represented low, values of 50--75% medium and \>75% represented substantial heterogeneity.

Results
=======

A total of 792 studies were screened by their abstracts ([Fig. 1](#f1-etm-0-0-8026){ref-type="fig"}). Out of the 12 studies retrieved for full-text analysis, 5 were excluded. The reasons for exclusion were as follows: The use of non-invasive ventilation in the control group ([@b19-etm-0-0-8026]), the use of supplementary oxygen during home activities ([@b20-etm-0-0-8026]), crossover trial ([@b21-etm-0-0-8026]), the absence of a control group ([@b22-etm-0-0-8026]), and trials on pre-tested subjects showing improvement with supplemental oxygen ([@b23-etm-0-0-8026]). A total of 7 trials were included in this systematic review and meta-analysis ([@b11-etm-0-0-8026]--[@b13-etm-0-0-8026],[@b15-etm-0-0-8026],[@b24-etm-0-0-8026]--[@b26-etm-0-0-8026]).

### Characteristics of the included studies

The details of studies included in the review are presented in [Table II](#tII-etm-0-0-8026){ref-type="table"}. The sample size was \<20 patients per group in all studies, apart from 1 ([@b25-etm-0-0-8026]). Only 1 trial had a large sample of 58 patients in the study and 53 patients in the control group ([@b25-etm-0-0-8026]). Room air was used in the control group in 1 trial ([@b11-etm-0-0-8026]), while compressed/humidified air was used in the remaining studies. The exercise protocol included cycle ergometry in 3 studies ([@b15-etm-0-0-8026],[@b24-etm-0-0-8026],[@b26-etm-0-0-8026]) and treadmill walking in 1 trial ([@b13-etm-0-0-8026]). Physical training was carried out in 3 sessions/week in all studies apart from 1 study ([@b11-etm-0-0-8026]), which utilized a 5 session/week protocol. The duration of each session varied from 30 min to 1 h. In 1 trial, utilizing a 24-week PR program, outcomes were assessed at 12 and 24 weeks. To maintain homogeneity with the remaining studies, which conducted a 6--10 week PR program, outcome data of 12 weeks from this trial were included ([@b26-etm-0-0-8026]).

### Outcomes and data analysis

The outcomes assessed varied across studies. Details of the outcome variables and conclusions of individual studies are presented in [Table III](#tIII-etm-0-0-8026){ref-type="table"}.

### Maximal exercise capacity

Maximal exercise capacity was tested by cycle ergometry in 4 trials ([@b11-etm-0-0-8026],[@b15-etm-0-0-8026],[@b24-etm-0-0-8026],[@b26-etm-0-0-8026]). The data of 55 participants in the study group and 54 in the control group were pooled for a meta-analysis. No statistically significant difference was found between the 2 groups in terms of power (random: MD = −2.38; 95% CI, −5.79 to 1.03; P=0.86, I^2^ = 0%) ([Fig. 2](#f2-etm-0-0-8026){ref-type="fig"}). Similarly, the maximum energy expenditure (VO~2~ max) did not differ significantly between the supplemental oxygen and control groups (random: MD = −0.01; 95% CI, −0.06 to 0.07; P=0.45, I^2^ = 0%) ([Fig. 3](#f3-etm-0-0-8026){ref-type="fig"}). End-of test dyspnea scores were pooled from 3 trials ([@b11-etm-0-0-8026],[@b15-etm-0-0-8026],[@b24-etm-0-0-8026]). The results of the meta-analysis indicated no significant advantage of supplemental oxygen in reducing dyspnea scores (random: MD = 0.79; 95% CI, 0.23 to 1.36; P=0.51, I^2^ = 0%) ([Fig. 4](#f4-etm-0-0-8026){ref-type="fig"}). End-of test oxygen saturation (SpO2%) was measured by 2 studies ([@b11-etm-0-0-8026],[@b15-etm-0-0-8026]). Both reported no advantage of supplemental oxygen.

### Constant power exercise capacity

Three trials ([@b11-etm-0-0-8026],[@b15-etm-0-0-8026],[@b24-etm-0-0-8026]) used cycle ergometry to measure constant power exercise capacity. Data were not homogenous to be pooled for a meta-analysis. Endurance capacity, measured as an increase in exercise time, increased only in the oxygen group in 1 study ([@b11-etm-0-0-8026]) (the change was not significant), while in another trial ([@b15-etm-0-0-8026]), it improved significantly in both groups. Isotime VO~2~ was recorded by 2 trials ([@b15-etm-0-0-8026],[@b24-etm-0-0-8026]). Both found no significant difference between the 2 groups. One trial ([@b15-etm-0-0-8026]) found end-of test dyspnea scores to be significantly improved in the oxygen group as compared to the control group. End-of test oxygen saturation (SpO2%), measured by 2 trials ([@b11-etm-0-0-8026],[@b15-etm-0-0-8026]), did not differ significantly between the 2 groups.

### Functional exercise capacity

Three studies ([@b11-etm-0-0-8026],[@b13-etm-0-0-8026],[@b26-etm-0-0-8026]) measured functional exercise capacity using 6-min walk tests (6MWT). Pooled data of 41 participants in the study group and 39 in the control group indicated no significant differences between the 2 groups (random: MD = −14.93; 95% CI, −32.64 to 2.78; P=0.93, I^2^ = 0%) ([Fig. 5](#f5-etm-0-0-8026){ref-type="fig"}). Two trials ([@b11-etm-0-0-8026],[@b13-etm-0-0-8026]) recorded end-of test dyspnea scores and end-of test oxygen saturation and found no significant difference between the supplemental oxygen and control groups.

### Shuttle walk tests

Incremental shuttle walk tests were used as an outcome measure in 2 trials ([@b12-etm-0-0-8026],[@b25-etm-0-0-8026]). While 1 study ([@b25-etm-0-0-8026]) found no significant difference between groups, the other study recorded a significant reduction in end-of test dyspnea scores in the oxygen group ([@b12-etm-0-0-8026]). Data from the endurance shuttle walk test from 1 trial ([@b25-etm-0-0-8026]) demonstrated significant benefits in both groups with no significant in-between group difference.

### Quality of life

Health-related quality of life was measured using the Chronic Respiratory Disease Questionnaire (CRQ) in 4 studies ([@b11-etm-0-0-8026],[@b12-etm-0-0-8026],[@b15-etm-0-0-8026],[@b25-etm-0-0-8026]). Data of 95 participants in the study group and 91 participants in the control group were analyzed. The results of meta-analysis of total scores indicated no difference between the 2 groups (random: MD = −0.09; 95% CI, −0.16 to −0.01; P=0.59, I^2^ = 0%) ([Fig. 6](#f6-etm-0-0-8026){ref-type="fig"}).

### Quality of included studies

The authors\' judgment of risk of bias of included trials is presented in [Fig. 7](#f7-etm-0-0-8026){ref-type="fig"}. A total of 6 of the 7 studies described an adequate randomization method ([@b11-etm-0-0-8026]--[@b13-etm-0-0-8026],[@b15-etm-0-0-8026],[@b25-etm-0-0-8026],[@b26-etm-0-0-8026]). Adequate information on allocation concealment was reported in 3 studies ([@b11-etm-0-0-8026],[@b12-etm-0-0-8026],[@b25-etm-0-0-8026]). The blinding of participants and outcome assessment was clearly reported in 4 trials ([@b15-etm-0-0-8026],[@b24-etm-0-0-8026]--[@b26-etm-0-0-8026]). One trial had a significant number of drop-outs from the study ([@b26-etm-0-0-8026]).

Discussion
==========

The primary objective of this systematic review and meta-analysis was to analyze the beneficial effect of supplemental oxygen during exercise training in patients with COPD. Overall, the results of this review can be categorized into 3 sub-headings: Exercise capacity, dyspnea scores and health-related quality of life.

Exercise tolerance is an important predictor of morbidity and mortality in COPD patients. A number of exercise testing protocols were utilized by the included studies. While maximal exercise testing measures the participants\' response to a gradually increasing workload, a constant power exercise test assesses the participants systemic response to a constant metabolic demand ([@b27-etm-0-0-8026]). Since maximal exercise capacity is seldom reached during daily activities, the metabolic load of day-to-day activities is more suitably assessed using the constant power exercise test or other functional exercise tests like 6 or 12 MWT and shuttle walk tests ([@b28-etm-0-0-8026]). These investigations are also more sensitive to changes following intervention for exercise training ([@b2-etm-0-0-8026]). Another disadvantage of a maximal exercise test is the high level of motivation required on behalf of the participant to achieve the actual maximal limit. Secondly, approximately 6--10% of day-to-day variation in VO~2~ max can be observed in patients with COPD ([@b29-etm-0-0-8026]). Maximal exercise test using cycle ergometry was utilized by 4 of the 7 included trials. On pooling of the data, supplemental oxygen during exercise training was not found to be beneficial in improving VO~2~ max and power output.

In the absence of homogenous data, quantitative analysis was not carried out of the 3 trials reporting constant power exercise tests. The results of endurance capacity, measured as an increase in exercise time wer ambiguous. Emtner *et al* ([@b15-etm-0-0-8026]), while reporting a significant improvement in exercise time in both groups, reported better outcomes in the supplemental oxygen group. The authors suggested that the results may have been underestimated as 16 tests in the oxygen-trained group were terminated at 30 min versus only 7 tests in the control group. Rooyackers *et al* ([@b11-etm-0-0-8026]) found an increase in the cycling time only in the experimental group with no change in the control group; however, the change not was statistically significant. Outcome measurements at specific time-points (isotime responses) during constant power exercise tests are effort-independent and allow for a more robust comparison of intervention effects ([@b30-etm-0-0-8026]). While our review indicates no significant change in VO~2~ max and cardiovascular parameters (heart rate and blood pressure) with supplemental oxygen therapy, Emtner *et al* ([@b15-etm-0-0-8026]) documented a slower and deeper pattern of breathing in the oxygen-trained group.

Non-laboratory functional exercise tests, such as 6MWT have been validated to assess the functional status of patients with COPD ([@b31-etm-0-0-8026]). Not only are they easy to perform and inexpensive, but standardization is also easy for measuring the effect of interventions. The results from the meta-analysis of 6MWT suggest no benefits with the use of supplemental oxygen during exercise training of patients with COPD. Similar results were found by Garrod *et al* ([@b12-etm-0-0-8026]) and Alison *et al* ([@b25-etm-0-0-8026]) during shuttle walk tests. Although some authors ([@b13-etm-0-0-8026]) have reported better performance of the oxygen group during training sessions, the outcome assessment on room air failed to demonstrate any benefit despite prolonged training. One possible explanation suggested is that control groups train under slight hypoxemia as compared to the oxygen groups. The 'slight hypoxemia' causes physiological stress, which is required for improving physical capacity ([@b13-etm-0-0-8026]).

Dyspnea is an important symptom that limits exercise tolerance in patients with COPD. The actual role of oxygen in improving dyspnea is complex and not yet well understood ([@b32-etm-0-0-8026]). Dyspnea was recorded as an outcome variable in majority trials of this review. However, meta-analysis for dyspnea scores measured on the Borg scale was conducted only for the maximal exercise test, which demonstrated no benefit of supplemental oxygen therapy. Garrod *et al* ([@b12-etm-0-0-8026]) demonstrated a reduction in end-of test dyspnea scores after shuttle walk tests but without any significant change of other variables like exercise capacity and health-related quality of life outcomes. The isolated dyspnea results may be attributed to the small sample size of the study.

PR has been shown to significantly improve quality of life outcomes in patients with COPD ([@b7-etm-0-0-8026]). PR programs include an exercise module and an education/psychological support module. While the exact contribution of each module in improving quality of life is unknown, a recent review suggested that self-management educational programs can significantly improve the quality of life of COPD patients ([@b33-etm-0-0-8026]). Health-related quality of life outcome was measured via CRQ in 4 studies ([@b11-etm-0-0-8026],[@b12-etm-0-0-8026],[@b15-etm-0-0-8026],[@b25-etm-0-0-8026]) included in the review. Our analysis failed to demonstrate any beneficial effect of supplemental oxygen in improving the quality of life of patients with COPD.

Some limitations of our study need to be elaborated. The strength of any systematic review and meta-analysis depends upon the homogeneity and quality of the included studies. The lack of homogeneity of the included trials is the largest drawback of this study. There was a wide variation in the methodology, intervention, exercise protocol and outcome measurements, which precluded a quantitative analysis for all variables. The inclusion criteria also varied between studies. While majority trials were carried out on participants who desaturate on exercise, studies by Emtner *et al* ([@b15-etm-0-0-8026]) and Spielmanns *et al* ([@b26-etm-0-0-8026]) focused only on patients with COPD who were normoxemic at rest and exercise. A sub-group analysis analyzing the effect of oxygen on each group was not possible considering the heterogeneity. Secondly, not all studies reported adequate allocation concealment with blinding of participants and outcome assessment. A lack of rigorous methodology could have affected results. Thirdly, the sample size of majority studies was small with less than 20 participants per group.

Nevertheless, this study is an important update over the previous review on this topic ([@b2-etm-0-0-8026]). Our results indicate that supplemental oxygen during the exercise training of patients with COPD does not improve exercise capacity, dyspnea scores and quality of life. However, the quality of the evidence is weak. Multi-center RCTs with homogenous methodology and intervention are required to provide stronger evidence on this subject.
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###### 

Eligibility criteria for inclusion in the systematic review.

             Participants                                               Intervention                                          Outcomes
  ---------- ---------------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------
  Included   Adult patients with COPD with one of the following:        i\) For the study group: Oxygen therapy provided      Any one of the following:
             i\) Best recorded EV1/FVC ratio \<0.7; ii) best recorded   via wall units/portable oxygen cylinders/Liquid       i\) Maximum exercise capacity or incremental exercise
             FEV1 \<80%                                                 cannisters. For the control group: Compressed air     capacity or timed walk tests.
                                                                        or room air.                                          ii\) Dyspnoea scores
                                                                        ii\) Intervention provided during exercise training   iii\) Quality of life outcomes
  Excluded   Patients with COPD on long-term oxygen therapy             i\) Intervention not used during exercise therapy.    Not studying any of the above-mentioned outcomes
                                                                        ii\) Long-term oxygen therapy like for daily home     
                                                                        activities                                            

COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in the first second.

###### 

Characteristics of included studies.

                                   Participants   Age in years, mean (SD)                                                                                                                                                                                                                                                                                                        
  -------------------------- ----- -------------- ------------------------- ------------ ------------ -------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --- ------------------------------------ ---------- -----------------------
  Rooyackers *et al*, 1997   RCT   12             12                        63 (5)       59 (13)      S: 4 lpm O~2~ by nasal cannula   20 min cycling (2 min exercise then 2 min rest), 5 min rowing, 5 min pulley (arm,                                                                                                     5   80 min with rest (51 min exercise)   10 weeks   ([@b11-etm-0-0-8026])
                                                                                                      C: Room air                      shoulder), 5 min back and abdominals, 3 min isometric strength training of arms and shoulders and legs, 3 min stair climb, 5 min chair sit/stand and slalom walk, 5 min arm weights                                                       
  Garrod *et al*, 2000       RCT   11             11                        64.3 (NR)    71.6 (NR)    S: 4 lpm O~2~ by nasal cannula   Upper limb at 1 kg, lower limb at no resistance, fast walk over 10 m, cycle                                                                                                           3   1 h                                  6 weeks    ([@b12-etm-0-0-8026])
                                                                                                      C: 4 lpm compressed air          ergometer unloaded until intolerance                                                                                                                                                                                                      
  Wadell *et al*, 2001       RCT   10             10                        64.6 (6.1)   68.3 (4.1)   S: 5 lpm O~2~ by nasal cannula   Treadmill walk                                                                                                                                                                        3   30 min                               8 weeks    ([@b13-etm-0-0-8026])
                                                                                                      C: 5 lpm compressed air                                                                                                                                                                                                                                                    
  Emtner *et al*, 2003       RCT   14             15                        66 (7)       67 (10)      S: 3 lpm O~2~ by nasal cannula   Cycle ergometry                                                                                                                                                                       3   45 min                               7 weeks    ([@b15-etm-0-0-8026])
                                                                                                      C: 3 lpm compressed air                                                                                                                                                                                                                                                    
  Scorsone *et al*, 2010     RCT   10             10                        67 (9)       68 (7)       S: 40% supplemental O~2~         Cycle ergometry                                                                                                                                                                       3   40 min                               8 weeks    ([@b24-etm-0-0-8026])
                                                                                                      C: Humidified air                                                                                                                                                                                                                                                          
  Spielmanns *et al*, 2014   RCT   19             17                        65 (8.7)     64 (8.4)     S: 4 lpm O~2~ by nasal cannula   Cycle ergometry                                                                                                                                                                       3   30 min                               12 weeks   ([@b26-etm-0-0-8026])
                                                                                                      C: 4 lpm compressed air                                                                                                                                                                                                                                                    
  Alison *et al*, 2019       RCT   58             53                        69 (7)       69 (8)       S: 5 lpm O~2~ by nasal cannula   Initially, 20 min of treadmill walking and 10 min stationary cycling, increased to                                                                                                    3   40 min                               8 weeks    ([@b25-etm-0-0-8026])
                                                                                                      C: 5 lpm air                     20 min of treadmill walking and 20 min stationary cycling by week 3                                                                                                                                                                       

SD, Standard Deviation; RCT, randomized controlled trial; S, study group; C, control group; min, minutes; l pm, liters per min.

###### 

Outcomes of included studies.

  Author, year    Outcomes assessed                                     Conclusions                                               (Refs.)
  --------------- ----------------------------------------------------- --------------------------------------------------------- -----------------------
  Rooyackers      i\) Maximal cycle ergometry-4 lpm O~2~ and room air   Pulmonary rehabilitation improved exercise                ([@b11-etm-0-0-8026])
  *et al*, 1997   ii\) Constant power cycle ergometry-30% O~2~ and      performance and quality of life in both                   
                  room air                                              groups. O~2~ supplementation during the                   
                  iii\) 6MWT-4 lpm O~2~ and room air                    training did not add to the effects of training           
                  iv\) Stair climb-up 4, plateau, down 3                on room air.                                              
                  v\) Weight lift-lift between racks                                                                              
                  vi\) Chronic respiratory Disease Questionnaire                                                                  
                  vii\) PFT-Spirometry and transfer coefficient for                                                               
                  carbon monoxide                                                                                                 
  Garrod          i\) Shuttle walk test                                 Supplemental O~2~ during training does little to          ([@b12-etm-0-0-8026])
  *et al*, 2000   ii\) Chronic respiratory Disease Questionnaire        enhance exercise tolerance although there is a            
                  iii\) Hospital Anxiety and Depression Scale           small benefit in terms of dyspnea. Patients with          
                  iv\) London Chest Activity of Daily Living Scale      severe disabling dyspnea may find symptomatic             
                                                                        relief with supplemental oxygen.                          
  Wadell          i\) 6MWT on 5 lpm O~2~ and 5 lpm compressed           Supplemental O~2~ did not further improve the             ([@b13-etm-0-0-8026])
  *et al*, 2001   air (random order) with a 1 h rest in between         training effect, compared with training with air,         
                  ii\) Arterial blood gas analysis                      in patients with chronic obstructive pulmonary disease.   
  Emtner          i\) Maximal cycle ergometry-30% O~2~ and              Supplemental O~2~ provided during high-intensity          ([@b15-etm-0-0-8026])
  *et al*, 2003   compressed air                                        training yields higher training intensity and             
                  ii\) Constant power cycle ergometry-30% O~2~          evidence of gains in exercise tolerance in                
                  and compressed air                                    laboratory testing.                                       
                  iii\) Chronic respiratory disease questionnaire                                                                 
                  iv\) SF-36                                                                                                      
                  v\) PFT-spirometry and lung volume                                                                              
                  vi\) Arterial blood gas analysis                                                                                
  Scorsone        i\) PFT                                               O~2~ supplementation does not contribute to               ([@b24-etm-0-0-8026])
  *et al*, 2010   ii\) Maximal cycle ergometry                          improved exercise performance in patients with            
                  iii\) Constant power cycle ergometry                  moderate to severe COPD.                                  
                  iv\) Arterial blood gas analysis                                                                                
  Spielmanns      i\) 6MWT-room air                                     O~2~ supplemental oxygen during the training              ([@b26-etm-0-0-8026])
  *et al*, 2014   ii\) Maximal cycle ergometry-room air                 program had no additional benefits in improving           
                  iii\) SF-36                                           quality of life and exercise capacity in subjects         
                                                                        with moderate-to-severe COPD.                             
  Alison          i\) Endurance shuttle walk test                       Both O~2~ and Air groups significantly improved           ([@b25-etm-0-0-8026])
  *et al*, 2019   ii\) Incremental shuttle walk test                    exercise capacity and health related quality of life      
                  iii\) Chronic Respiratory Disease Questionnaire       with no greater benefit from training with                
                  iv\) Dyspnoea-12 Questionnaire                        supplemental O~2~ than with medical air.                  

lpm, liter per minute; 6MWT, 6-min walking distance test; SF-36, Medical Outcomes Survey Short Form 36 questionnaire; PFT, Pulmonary Function Test.
